About this trial
The goal of this clinical trial is to learn if acupuncture can play a role in reducing pain and improving the quality of life of post-radiotherapy nasopharyngeal cancer mucositis patients. The main questions it aims to answer are:
\- Do manual acupuncture and medication therapy affect pain intensity as measured by the visual analogue scale (VAS) in patients with oral mucositis compared with sham manual acupuncture and medication?
Participants will receive acupuncture therapy 2 times a week for 3 weeks
Eligibility criteria
Qualifiers
Subjects who have been proven by anatomical pathology examination to have a diagnosis of Nasopharyngeal Cancer.
Subjects with adult Nasopharyngeal Cancer aged 19 years - 59 years.
Nasopharyngeal Cancer Patients, who underwent bilateral Head and Neck radiotherapy.
Patients diagnosed with mucositis.
Disqualifiers
Nasopharyngeal Cancer patients who have distant metastases (based on the Tumor Node Metastasis (TNM) classification with the presence of metastases (M1)).
Subjects who still smoke and consume alcohol to date.
Patients have contraindications for manual acupuncture, namely the use of anti-coagulant drugs, the presence of infection or wounds at the puncture site, emergency conditions, and pregnancy.
There is a history of allergy to stainless steel materials.
Trial design
Treatments tested in this trial
- Verum Acupuncture
- Sham Acupuncture